Try a new search

Format these results:

Searched for:

in-biosketch:true

person:simonn02

Total Results:

281


Bereavement: course, consequences, and care

Zisook, Sidney; Iglewicz, Alana; Avanzino, Julie; Maglione, Jeanne; Glorioso, Danielle; Zetumer, Samuel; Seay, Kathryn; Vahia, Ipsit; Young, Ilanit; Lebowitz, Barry; Pies, Ronald; Reynolds, Charles; Simon, Naomi; Shear, M Katherine
This paper discusses each of several potential consequences of bereavement. First, we describe ordinary grief, followed by a discussion of grief gone awry, or complicated grief (CG). Then, we cover other potential adverse outcomes of bereavement, each of which may contribute to, but are not identical with, CG: general medical comorbidity, mood disorders, post-traumatic stress disorder, anxiety, and substance use.
PMID: 25135781
ISSN: 1535-1645
CID: 2724912

Gender differences in oxytocin-associated disruption of decision bias during emotion perception

Lynn, Spencer K; Hoge, Elizabeth A; Fischer, Laura E; Barrett, Lisa Feldman; Simon, Naomi M
Oxytocin is associated with differences in the perception of and response to socially mediated information, such as facial expressions. Across studies, however, oxytocins effect on emotion perception has been inconsistent. Outside the laboratory, emotion perception involves interpretation of perceptual uncertainty and assessment of behavioral risk. An account of these factors is largely missing from studies of oxytocins effect on emotion perception and might explain inconsistent results across studies. Of relevance, studies of oxytocins effect on learning and decision-making indicate that oxytocin attenuates risk aversion. We used the probability of encountering angry faces and the cost of misidentifying them as not angry to create a risky environment wherein bias to categorize faces as angry would maximize point earnings. Consistent with an underestimation of the factors creating risk (i.e., encounter rate and cost), men given oxytocin exhibited a worse (i.e., less liberal) response bias than men given placebo. Oxytocin did not influence womens performance. These results suggest that oxytocin may impair mens ability to adapt to changes in risk and uncertainty when introduced to novel or changing social environments. Because oxytocin also influences behavior in non-social realms, oxytocin pharmacotherapy could have unintended consequences (i.e., risk-prone decision-making) while nonetheless normalizing pathological social interaction.
PMCID:4086323
PMID: 24814142
ISSN: 1872-7123
CID: 2281342

De novo fear conditioning across diagnostic groups in the affective disorders: evidence for learning impairments

Otto, Michael W; Moshier, Samantha J; Kinner, Dina G; Simon, Naomi M; Pollack, Mark H; Orr, Scott P
De novo fear conditioning paradigms have served as a model for how clinical anxiety may be acquired and maintained. To further examine variable findings in the acquisition and extinction of fear responses between clinical and nonclinical samples, we assessed de novo fear conditioning outcomes in outpatients with either anxiety disorders or depression and healthy subjects recruited from the community. Overall, we found evidence for attenuated fear conditioning, as measured by skin conductance, among the patient sample, with significantly lower fear acquisition among patients with depression and posttraumatic stress disorder. These acquisition deficits were evident in both the simple (considering the CS+only) and differential (evaluating the CS+in relation to the CS-) paradigms. Examination of extinction outcomes were hampered by the low numbers of patients who achieved adequate conditioning, but the available data indicated slower extinction among the patient, primarily panic disorder, sample. Results are interpreted in the context of the cognitive deficits that are common to the anxiety and mood disorders, with attention to a range of potential factors, including mood comorbidity, higher-and lower-order cognitive processes and deficits, and medication use, that may modulate outcomes in fear conditioning studies, and, potentially, in exposure-based cognitive behavioral therapy.
PMCID:4603557
PMID: 25022773
ISSN: 1878-1888
CID: 2724932

Anxiety sensitivity in bereaved adults with and without complicated grief

Robinaugh, Donald J; McNally, Richard J; LeBlanc, Nicole J; Pentel, Kimberly Z; Schwarz, Noah R; Shah, Riva M; Nadal-Vicens, Mireya F; Moore, Cynthia W; Marques, Luana; Bui, Eric; Simon, Naomi M
Complicated grief (CG) is a bereavement-specific syndrome chiefly characterized by symptoms of persistent separation distress. Physiological reactivity to reminders of the loss and repeated acute pangs or waves of severe anxiety and psychological pain are prominent features of CG. Fear of this grief-related physiological arousal may contribute to CG by increasing the distress associated with grief reactions and increasing the likelihood of maladaptive coping strategies and grief-related avoidance. Here, we examined anxiety sensitivity (AS; i.e., the fear of anxiety-related sensations) in two studies of bereaved adults with and without CG. In both studies, bereaved adults with CG exhibited elevated AS relative to those without CG. In study 2, AS was positively associated with CG symptom severity among those with CG. These findings are consistent with the possibility that AS contributes to the development or maintenance of CG symptoms.
PMCID:4118557
PMID: 25075646
ISSN: 1539-736x
CID: 2281362

Response to Silberman [Letter]

Pollack, Mark H; Stein, Murray; Simon, Naomi; Van Ameringen, Michael
PMID: 24980175
ISSN: 1535-7228
CID: 2724942

Cognitive Function in Complicated Grief [Meeting Abstract]

Hall, Charles; Begley, Amy; Butters, Meryl; Corey-Bloom, Jody; Lebowitz, Barry; Reynolds, Charles F; Shear, MKatherine; Simon, Naomi; Zisook, Sidney
ISI:000334101802181
ISSN: 1873-2402
CID: 2725822

Influence of RGS2 on sertraline treatment for social anxiety disorder

Stein, Murray B; Keshaviah, Aparna; Haddad, Stephen A; Van Ameringen, Michael; Simon, Naomi M; Pollack, Mark H; Smoller, Jordan W
Only a minority of patients with social anxiety disorder (SAD) has a robust therapeutic response to evidence-based serotonin reuptake inhibitor (SSRI) treatment. To help improve the personalized medicine approach to psychiatric care, we evaluated several candidate genetic predictors of SSRI response in SAD. At the start of a randomized controlled trial (NCT00282828), 346 patients with SAD at three sites received protocol-driven, open-label treatment with sertraline, up to 200. mg/d over 10 weeks. Efficacy was determined using a continuous measure of outcome (Liebowitz Social Anxiety Scale (LSAS)) and dichotomous indicators of response (LSAS
PMCID:3988537
PMID: 24154666
ISSN: 1740-634x
CID: 2281312

Gender moderates the effect of oxytocin on social judgments

Hoge, Elizabeth A; Anderson, Eric; Lawson, Elizabeth A; Bui, Eric; Fischer, Laura E; Khadge, Shradha D; Barrett, Lisa Feldman; Simon, Naomi M
OBJECTIVE: The neuropeptide oxytocin is implicated in social processing, and recent research has begun to explore how gender relates to the reported effects. This study examined the effects of oxytocin on social affective perception and learning. METHODS: Forty-seven male and female participants made judgments of faces during two different tasks, after being randomized to either double-blinded intranasal oxytocin or placebo. In the first task, "unseen" affective stimuli were presented in a continuous flash suppression paradigm, and participants evaluated faces paired with these stimuli on dimensions of competence, trustworthiness, and warmth. In the second task, participants learned affective associations between neutral faces and affective acts through a gossip learning procedure and later made affective ratings of the faces. RESULTS: In both tasks, we found that gender moderated the effect of oxytocin, such that male participants in the oxytocin condition rated faces more negatively, compared with placebo. The opposite pattern of findings emerged for female participants: they rated faces more positively in the oxytocin condition, compared with placebo. CONCLUSIONS: These findings contribute to a small but growing body of research demonstrating differential effects of oxytocin in men and women.
PMID: 24911580
ISSN: 1099-1077
CID: 2281352

RELATIONSHIPS OF TUMOR EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) GENOTYPES WITH MAJOR DEPRESSIVE DISORDER AND CYTOKINES IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC) [Meeting Abstract]

Pirl, William; Traeger, Lara; Greer, Joseph; Eusebio, Justin; Simon, Naomi; Temel, Jennifer
ISI:000334235100080
ISSN: 1534-7796
CID: 2725832

Cortico-limbic responses to masked affective faces across ptsd, panic disorder, and specific phobia

Killgore, William D S; Britton, Jennifer C; Schwab, Zachary J; Price, Lauren M; Weiner, Melissa R; Gold, Andrea L; Rosso, Isabelle M; Simon, Naomi M; Pollack, Mark H; Rauch, Scott L
BACKGROUND: Exaggerated amygdala and reduced ventromedial prefrontal cortex (vmPFC) responsiveness during emotional processing have been reported in studies examining individual anxiety disorders. Studies are needed, however, which directly compare activation of amygdalo-cortical circuitry across multiple anxiety disorders within the same study. Here we compared cortico-limbic neurocircuitry across three different anxiety disorders using a well-validated emotional probe task. METHODS: Sixty-five adult volunteers, including 22 healthy controls (HC) and participants meeting DSM-IV criteria for either posttraumatic stress disorder (14 PTSD), panic disorder (14 PD), or specific animal phobia (15 SP), underwent functional magnetic resonance imaging (fMRI) at 3 T while passively viewing backward-masked images of faces expressing fear, happy, and neutral emotions. RESULTS: A group comprising all three anxiety disorders showed greater activation within the left amygdala and reduced activation within the vmPFC compared to the HC group during the masked fear versus neutral condition. Pairwise group comparisons showed that amygdala activation only reached significance for the PTSD versus HCs, whereas decreased vmPFC was only evident for SP and PD groups versus the HC group. Furthermore, activation did not differ among the anxiety groups when contrasted directly with one another. A similar pattern was observed for masked happy versus neutral faces. CONCLUSIONS: Exclusive of specific diagnostic category, anxiety disorders were generally associated with increased activation of the amygdala and reduced activation within vmPFC. Categorical distinctions were generally weak or not observed and suggest that functional differences may reflect the magnitude of responses within a common neurocircuitry across disorders rather than activation of distinct systems.
PMCID:4593618
PMID: 23861215
ISSN: 1520-6394
CID: 2281262